Kupewa: Optimizing Implementation Strategies for Cervical Cancer Prevention
2 other identifiers
interventional
7,000
1 country
1
Brief Summary
The goal of this clinical trial is identify an effective and implementable set of implementation strategies to increase cervical cancer prevention in Malawi. The main questions it aims to answer are:
- 1.Which implementation strategies produce the greatest increase in provider recommendation for, and uptake of, cervical cancer prevention tools among people receiving HIV care.
- 2.What is the acceptability, appropriateness, feasibility, and cost of these implementation strategies.
- 3.What is the sustained effect of these implementation strategies. The implementation strategies will be conducted with health workers (clinical officers, nurses, and medical assistants): training, coaching, and a reminder system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Jul 2025
Longer than P75 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 3, 2025
CompletedFirst Posted
Study publicly available on registry
June 11, 2025
CompletedStudy Start
First participant enrolled
July 8, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2029
April 30, 2026
August 1, 2025
1.1 years
June 3, 2025
April 29, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Difference in prevalence of discussions surrounding methods of cervical cancer prevention
Discussions about methods of cervical cancer prevention will be reported by clients following each routine HIV care visit. This rate is defined as the percentage of visits during which there is a discussion about methods of cervical cancer prevention. This rate will be compared between the groups with and without each intervention component.
Months 7-18
Secondary Outcomes (2)
Difference in prevalence of completing a cervical cancer prevention program
Months 7-18
Difference in prevalence of initiating a cervical cancer prevention program among those uninitiated
Months 7-18
Other Outcomes (1)
Acceptability of the implementation strategies
Months 1-9
Study Arms (8)
Condition 1: In-person training
ACTIVE COMPARATORCondition 2: In-person training + Prompt
EXPERIMENTALCondition 3: In-person training + Coaching
EXPERIMENTALCondition 4: In-person training + Prompt + Coaching
EXPERIMENTALCondition 5: Virtual training
EXPERIMENTALCondition 6: Virtual training + Prompt
EXPERIMENTALCondition 7: Virtual training + Coaching
EXPERIMENTALCondition 8: Virtual training + Prompt + Coaching
EXPERIMENTALInterventions
Visual aide to remind providers to discuss cervical cancer prevention methods.
An in-person educational session.
A virtual educational session.
Short video vignettes plus reinforcing messages
Eligibility Criteria
You may qualify if:
- Health workers: People who provide medical care and counseling (typically medical assistants, clinical officers, and nurses), and interact with adolescent girls and young women aged 9-24 and/or their parents/caregivers.
- Clients: Non-pregnant females aged 9-24 (for those aged 9-17, their male or female parent/guardian will also be eligible for participation) who present for HIV care at a participating health facility during the study period.
You may not qualify if:
- Health workers: Less than 18 years of age, or not an active and regular provider of medical care or counseling at the facility, or unable or unwilling to provide informed consent.
- Clients: \<9 or \>24 years old, or pregnancy, or unable or unwilling to provide informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Cancer Institute (NCI)collaborator
- University of California, Los Angelescollaborator
- Partners in Hope, Inc.collaborator
- New York Universitylead
Study Sites (1)
Partners in Hope
Lilongwe, Malawi
Study Officials
- PRINCIPAL INVESTIGATOR
Corrina Moucheraud
New York University
- PRINCIPAL INVESTIGATOR
Risa M Hoffman
University of California, Los Angeles
- PRINCIPAL INVESTIGATOR
Sam Phiri
Partners in Hope, Inc.
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 3, 2025
First Posted
June 11, 2025
Study Start
July 8, 2025
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
August 1, 2029
Last Updated
April 30, 2026
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Access Criteria
- Survey data will be deposited into a data repository after it has been fully de-identified. De-identified focus group discussion data will be available on a by-request basis via a data repository.
Fully deidentified survey data and focus group discussion transcripts